CIP
HAE icon

Chartwell Investment Partners’s Haemonetics HAE Stock Holding History

Chartwell Investment Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,181
Closed -$888K – 435
2020
Q3 		$888K Hold
10,181
– – 0.03% 355
2020
Q2 		$912K Sell
10,181
-11,028
-52% -$1.11M 0.04% 336
2020
Q1 		$2.11M Sell
21,209
-26,756
-56% -$2.9M 0.1% 243
2019
Q4 		$5.51M Buy
47,965
+16,776
+54% +$2.03M 0.18% 184
2019
Q3 		$3.93M Buy
+31,189
New +$3.96M 0.13% 229
2018
Q2 		– Sell
-349,013
Closed -$25.5M – 496
2018
Q1 		$25.5M Buy
349,013
+23,895
+7% +$1.64M 0.87% 9
2017
Q4 		$18.9M Sell
325,118
-11,895
-4% -$626K 0.64% 27
2017
Q3 		$15.1M Sell
337,013
-8,868
-3% -$368K 0.52% 64
2017
Q2 		$13.7M Sell
345,881
-14,975
-4% -$615K 0.51% 70
2017
Q1 		$14.6M Buy
360,856
+850
+0.2% +$33.2K 0.53% 67
2016
Q4 		$14.5M Sell
360,006
-9,507
-3% -$358K 0.49% 66
2016
Q3 		$13.4M Sell
369,513
-36,100
-9% -$1.24M 0.24% 135
2016
Q2 		$11.8M Buy
405,613
+225
+0.1% +$6.8K 0.21% 148
2016
Q1 		$14.2M Buy
405,388
+11,725
+3% +$379K 0.27% 103
2015
Q4 		$12.7M Buy
393,663
+600
+0.2% +$19.5K 0.26% 113
2015
Q3 		$12.7M Sell
393,063
-20,550
-5% -$773K 0.27% 117
2015
Q2 		$17.1M Sell
413,613
-1,013
-0.2% -$42.7K 0.33% 104
2015
Q1 		$18.6M Buy
414,626
+5,547
+1% +$232K 0.36% 105
2014
Q4 		$15.3M Sell
409,079
-89,720
-18% -$3.29M 0.32% 121
2014
Q3 		$17.4M Buy
498,799
+67,320
+16% +$2.4M 0.39% 82
2014
Q2 		$15.2M Buy
431,479
+40,935
+10% +$1.37M 0.32% 135
2014
Q1 		$12.7M Sell
390,544
-7,805
-2% -$298K 0.26% 154
2013
Q4 		$16.8M Sell
398,349
-12,895
-3% -$531K 0.34% 115
2013
Q3 		$16.4M Buy
411,244
+55,425
+16% +$2.33M 0.37% 102
2013
Q2 		$14.7M Buy
+355,819
New +$14.4M 0.37% 95

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Chartwell Investment Partners's HAE Position: Q4 2020 in Review

Chartwell Investment Partners sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 10,181 shares — an estimated $888K sold.

Chartwell Investment Partners first reported a position in HAE in Q2 2013 and held it in 25 quarters. The position peaked at $25.5M in Q1 2018. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Chartwell Investment Partners reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 10,181 Haemonetics shares in Q4 2020, an estimated $888K.
  • Chartwell Investment Partners first reported a position in Haemonetics in Q2 2013 and held it in 25 quarters.
  • Chartwell Investment Partners's Haemonetics position peaked at $25.5M in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Chartwell Investment Partners's 13F filing for Q4 2020, filed 9 Feb 2021.